Jonathan Goldstein, MD
Gastroenterology · Rochester, NYNPI 1396822706
Payments from drug & device makers
Across 502 payments — averaging $1917.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342K
- Takeda Pharmaceuticals U.S.A., Inc.$304K
- Braintree Laboratories, Inc.$150K
- Lilly USA, LLC$88K
- Genentech, Inc.$37K
- Johnson & Johnson$15K
- plus $27K from 19 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 144 | $341,877 |
| Takeda Pharmaceuticals U.S.A., Inc. | 97 | $303,939 |
| Braintree Laboratories, Inc. | 49 | $149,569 |
| Lilly USA, LLC | 82 | $88,262 |
| Genentech, Inc. | 10 | $37,042 |
| Johnson & Johnson(2 entities) | 42 | $14,968 |
| F. Hoffmann-la Roche AG | 3 | $13,000 |
| Phathom Pharmaceuticals, Inc. | 5 | $6,607 |
| Ferring Pharmaceuticals Inc. | 9 | $3,942 |
| Ferring Pharmaceuticals AS | 3 | $2,350 |
| Pfizer | 22 | $257 |
| Gilead | 9 | $133 |
| Bristol Myers Squibb | 6 | $122 |
| Genentech USA, Inc. | 1 | $91 |
| Olympus America Inc. | 1 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Ironwood Pharmaceuticals, Inc | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| QOL Medical, LLC | 2 | $29 |
| Intercept Pharmaceuticals, Inc. | 2 | $28 |
| UCB, Inc. | 1 | $20 |
| Cook Medical LLC | 1 | $17 |
| Aries Pharmaceuticals, Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
How this compares
$962,568 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Rochester
- Jonathan WilmotRochester$984K
- Jonathan HuangRochester$633K
- Michael GerdisYonkers$11.9M
- David HudesmanNew York$3.6M
- Ellen ScherlNew York$2.9M
- Igor GrosmanBrooklyn$2.8M
- Bruce SandsNew York$2.8M
- Arun SwaminathNew York$2.7M
- Sonal KumarNew York$2.3M
- David Carr LockeNew York$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.